Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

Condition:   NorovirusInterventions:   Biological: Norovirus Bivalent VLP Vaccine;   Drug: Placebo (Saline);   Biological: Norovirus Bivalent VLP VaccineSponsor:   TakedaNot yet recruiting - verified May 2014

Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials